ATYR Pharma

Forecast & Rating9 analysts currently cover ATYR Pharma, with about 44.4% giving a positive rating — meaning they expect the stock to rise. The average price target is $2.86, about 503.7% upside from the current price of $0.47. Price targets range from $1.00 to $7.00 — a wide spread, showing clear disagreement over just how much ATYR Pharma can rise. For you, this means institutional views on ATYR Pharma are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jul 16, 2026; for reference only and not investment advice.